Prognostic factors in astrocytomas: Relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival

Neoplasma

Volumn 44, Issue 5, 1997, Pages 299-304

  Ehrmann Jr , J ^a   Kolar Z ^a   Voitesek B ^b   Kala, M ^a   Komenda, S ^a   Oulton, A ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Astrocytoma; BCL 2; MDM 2; p53; Proliferative activity; Survival

Indexed keywords

CYCLINE; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN BIOPSY; CANCER GRADING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN DETERMINATION;

EID: 0031398767     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. BÁRTEK, J., BÁRTKOVA, J., VOJTÈŠEK, B., STAŠKOVÁ, Z., LUKÁŠ, J., REYTHER, A., KOVAŘIK, J., MIDGLEY, C.A., GANNON, J.V., LANE, D.P.: Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene, 6, 1991, 1699-1703.
2. BHARGAVA, V., KELL, D.L., VAN DE RUN, M.: Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am. J. Pathol., 145, 1994, 535-540.
3. BUESO RAMOS, C.E., YANG, Y., DE LEON, E., MCCOWN, P., STASS, S.A., ALBITAR, M.: The human Mdm-2 oncogene is overexpressed in leucaemias. Blood, 82, 1993, 2617-2623.
4. CHEN, C.Y., OLINER, J.D., ZHAN, Q., FORNACE, A.J. JR., VOGELSTEIN, B., KASTAN, M.B.: Interactions between p53 and Mdm-2 in a mammalian cell cycle checkpoint pathway. Proc. Natl. Acad. Sci., USA, 91, 1994, 2684-2688.
5. CHILOSI, M., DOGLIONI, C., MENESTRINA, F., MONTAGNA, L., RIGO, A., LESTANI, M., BARBARESCHI, M., SCARPA, A., MARIUZZI, G.M., PIZZOLO, G.: Abnormal expression of the p53 binding protein Mdm-2 in Hodgkin's disease. Blood, 84, 1994, 4295-4300.
6. COLOMBEL, M., SYMMANS, F., GIL , S.: Detection of the apoptosis suppressing oncoprotein Bcl-2 in hormone refractory human prostate cancers. Am. J. Pathol., 143, 1993, 390-400.
7. DAUMAS-DUPORT, C., SCHEITHAUER, B., O'FALLON, J.: Grading of astrocytomas. A simple and reproducible method. Cancer, 62, 1988, 2152-2165.
8. DRACH, L.M., KAMMERMEIER, M., NEIRICH, U., JACOBI, G., KORNHUBER, B., LORENZ, R., SCHLOTE, W.: Accumulation of nuclear p53 protein and prognosis of astrocytomas in childhood and adolescence. Clin. Neuropathol., 15, 1996, 67-73.
9. EHRMANN, J. JR., KOLÁŘ, Z., KALA, M., VOJTĚŠEK, B., KOMENDA, S.: Expression of p53 in glioblastoma multiforme cells: Relationship to survival, proliferation and glycosylation. Čs. Patol., 31, 1995, 87-91.
10. ESRIG, D., ELMAJIAN, D., GROSHEIM, S., FREEMAN, J.A., STEIN, J.P., CHEN, S.C., NICHOLS, P.W., SKINNER, D.G., JONES, P.A., COLE, R.J.: Accumulation of nuclear p53 and tumor progression in bladder cancer. N.Engl. J. Med., 331, 1994, 1259-1264.
11. FORUS, A., FLORENCES, V.A., MAELANDSMO, G.M., FORSTAD, O., MYKLEBOST, O.: The protooncogene CHOP/GADD 153 involved in growth arrest and DNA damage response is amplified in a subset of human sarcomas. Cancer Genet, Cytogenet., 78, 1994, 165-171.
12. HE, J., REIFENBERGER, G., LIU, L., COLLINS, V.P., JAMES, C.D.: Analysis of glioma cell lines for amplification and overexpression of mdm-2. Genes Chromozom. Cancer, 11, 1994, 91-96.
13. HOFFMAN , B., LIEBERMANN, D.A.: Molecular controls of apoptosis: Differentiation/growth arrest primary response genes, protooncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene, 9, 1994, 1807-1812.
14. JOENSUU, H., PYLKKANEN, L., TOIKKANEN, S.: Bcl-2 protein expression and long term survival in breast cancer. Am. J. Pathol., 145, 1994, 1191-1198.
15. KASTAN, M.B., ONKYEHWERE, O., SIDRANSKI, D., VOGELSTEIN, B., CRAIG, R.W.: Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 1991, 6304-6311.
16. KORSMEYER, S.J.: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood, 80, 1992, 879-886.
17. KRAJEWSKI, S., BODRUG, S., GASCOYNE, R., BEREAN, K., KRAJEWSKA, M., REED, J.C.: Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am. J. Pathol., 145, 1994, 515-525.
18. KRAUS, J.A., BOLLN, C., WOLF, H.K., SCHLEGEL, U.: p53 alterations and clinical outcome in low grade astrocytomas. Clin. Neuropathol., 12, 1993, 254-259.
19. KRISHNA, M., SMITH, T.W., RECHT, L.D.: Expression of Bcl-2 in reactive and neoplastic astrocytes : Lack of correlation with presence or degree of malignancy. J. Neurosurg., 83, 1995, 1017-1022.
20. LANG, F.F., MILLER, D.C., PISHARODY, S., KOSLOW, M., NEWCOMB, E.W.: High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic low grade and anaplastic astrocytomas. Oncogene, 9, 1994, 949-954.
21. LIANES, P., ORLOW, I., ZHANG, Z.F., OLIVA, M.R., SARKIS, A.S., REUTER, V.E., CORDON CARDO, C.: Altered patterns of Mdm-2 and TP53 expression in human bladder cancer. J. Natl. Canc. Inst., 86, 1994, 1325-1330.
22. LU, Q.L., ELIA, E., LUCAS, S.: Bcl-2 protooncogene expression in Epstein Barr virus associated nasopharyngeal carcinoma. Int. J. Cancer, 53, 1993, 29-35.
23. MCDONNEL, T.J.: Cell division versus cell death : A functional model of multistep neoplasia. Mol. Carcinogenesis, 8, 1993, 209-213.
24. MCDONNEL, T.J., DEANE, V., PLATT, F.: Bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell, 57, 1989, 78-88.
25. MARCHETTI, A., BUTTILLA, F., MERLO, G., DIELLA, F., PELLEGRINI, S., PEPE, S., MACCHIARINI, P., CHELLA, A., ANGELETTI, C.A., CALLAHAN, R.: p53 alterations in non small lung cancers with metastatic involvement of hilar and mediastinal lymph nodes.Cancer Res., 53, 1993, 2846-2851.
26. MELTZER, P.S.: MDM-2 and p53: A question of balance. J. Natl. Canc. Inst., 86, 1994, 1265-1266.
27. MOSNER, J., DEPPERT, W.: p53 and Mdm-2 are expressed independently during cellular proliferation. Oncogene, 9, 1994, 3321-3328.
28. OLINER, J.D., KINSLER, K.W., MELTZER, P.S., GEORGE, D.L., VOGELSTEIN, B.: Amplification of a gene encoding a p53 associated protein in human sarcomas. Nature, 358, 1992, 80-83.
29. OLSON, D.C., MARECHAL, V., MOMAD, J., CHEN, J., ROMOCKI, C., LEVINE, A.J.: Identification and characterization of multiple Mdm-2 proteins and Mdm-2/p53 protein complexes. Oncogene, 8, 1993, 2353-2360.
30. PICKSLEY, S.M., VOJTĚŠEK, B., SPARKS, A., LANE, D.P.: Immunohistochemical analysis od the interaction of p53 and Mdm-2: Fine mapping of the Mdm-2 binding site on p53 using synthetic peptide. Oncogene, 9, 1994, 2523-2529.
31. QI LONG, L.U., ABEL, P., FOSTER, C.M.S., LALANI EL NASIR: Bcl-2: Role in epithelial differentiation and oncogenesis. Human Pathol., 27, 1996, 102-110.
32. QUESNEL, B., PREUDHOMME, C., OSCIER, D., LEPELLEY, P., COLLYND HOOGHE, M., FACON, T., ZANDECKI, M., FENAUX, P.: Overexpression of the mdm-2 gene is found in some cases of haematological malignancies. Br. J. Haematol., 88, 1994, 415-418.
33. REIFENBERGER, G., REIFENBERGER, J., ICHIMURA, K., MELTZER, P.S., COLLINS, V.P.: Amplification of multiple genes from chromozomal region 12q1314 in human malignant gliomas preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS and MDM-2.Cancer Res., 54, 1994, 649-652.
34. SCHOTTELIUS, A, BRENNSCHEIDT, U., LUDWIG, W.D., MERTELSMANN, R.H., HERMANN, F., LUBBERT, M.: Mechanism of p53 alteration in acute leucaemias. Leukemia, 8, 1994, 1673-1681.
35. THOR, A.D., MOORE, D.H., EDGERTON, S.M., KAWASAKI, E.S., REIHSAUS, E., LYNCH, A.T., MARCUS, J.N., SCHWARTZ, L., CHEN, L.C., MAYALL, B.H.: Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers. J. Natl. Cancer Inst., 84, 1992, 845-855.
36. TSUJIMOTO, Y., CROCE, C.M.: Analysis of the structure, transcripts and protein products of bcl-2, gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci., USA, 83, 1986, 5214-5218.
37. WU, X., BAYLE, J.H., OLSON, D.C., LEVINE, A.J.: The p53/Mdm-2 autoregulatory feedback loop. Genes Dev., 7, 1993, 1126-1132.